Alps Advisors Inc Moderna, Inc. Transaction History

Alps Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $1,183 - $2,100	-10 Reduced 0.41%	2,406 $432,000
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $9,563 - $15,728	81 Added 3.47%	2,416 $286,000
Q2 2022 Aug 11, 2022	SELL	$117.13 - $176.59 $2,811 - $4,238	-24 Reduced 1.02%	2,335 $334,000
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $188,678 - $350,694	1,492 Added 172.09%	2,359 $406,000
Q4 2021 Feb 09, 2022	BUY	$225.82 - $368.51 $4,064 - $6,633	18 Added 2.12%	867 $220,000
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $188,393 - $411,315	849 New	849 $327,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.